文献速递乳腺乳腺X线

70岁以上女性选择继续接受乳腺筛查:寻求支持知情选择的证据

Opting into breast screening over the age of 70 years: seeking evidence to support informed choice.
PubMed 文献 · Clin Radiol · 2022-06-14

老年女性继续乳腺筛查的 harms 可能大于获益(原文为 may outweigh)。

要点

  • 乳腺癌死亡比例随诊断年龄增高而下降,77岁起死于其他原因者多于死于乳腺癌者。
  • 乳腺X线筛查能准确识别老年女性乳腺癌,但检出癌症多属中或低风险。
  • 作者认为老年女性继续筛查的 harms 可能大于获益,该信息应告知所有老年女性。

核心结论

  • 老年女性继续乳腺筛查的 harms 可能大于获益(原文为 may outweigh)。
  • 该信息应提供给所有老年女性(原文为 should be available)。

研究设计与样本

  • 筛查结局指标包括召回评估、评估结局及肿瘤特征;肿瘤按分级和浸润 presence 分为高、中、低风险。
  • 死亡数据与诊断时年龄链接,并记录死因。

诊断标准与关键数值

  • 肿瘤按分级和浸润 presence 分为高风险、中风险、低风险三类。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To provide evidence specific to the Scottish population regarding the risk-benefit balance of women >70 years opting into continued breast screening, which may be used as a basis for patient information documentation.

MATERIALS AND METHODS: The present study consisted of a parallel, retrospective data analysis of breast cancer mortality data for breast cancer cases diagnosed between 2009 and 2013 (n=22,013) followed up to 31/12/18, and breast screening programme data from 2010 and 2015 (n=47,235). Screening outcome measures included recall for assessment, oncome of assessment, and tumour features. Tumours were classified as high, intermediate, or low risk according to grade and presence of invasion. Mortality data were linked to age at diagnosis and cause of death was recorded.

RESULTS: The proportion of all deaths due breast cancer is inversely related to age at diagnosis. From 77 years, women are more likely to die with breast cancer, than directly due to breast cancer. Mammographic screening accurately identifies breast cancer in older women; however, many of the cancers detected were considered intermediate or low risk.

CONCLUSIONS: Harms may outweigh the benefits of continued breast screening in older women. This information should be available to all older women.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Savaridas, Gierlinski, Warwick, et al. Opting into breast screening over the age of 70 years: seeking evidence to support informed choice. Clin Radiol. 2022. PMID: 35710529. doi:10.1016/j.crad.2022.01.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。